Dr. Reddy's Laboratories
RDY
#1729
Rank
NZ$19.98 B
Marketcap
NZ$23.90
Share price
-0.50%
Change (1 day)
-2.63%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$1.13 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total debt is NZ$1.13 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dr. Reddy's Laboratories - Total debt on balance sheet (from 2001 to 2025)

Total debt by year

Year Total debt Change
2025-03-31NZ$0.96 B140.55%
2024-03-31NZ$0.40 B53.21%
2023-03-31NZ$0.26 B-59.28%
2022-03-31NZ$0.64 B8.46%
2021-03-31NZ$0.59 B20.25%
2020-03-31NZ$0.49 B-39.14%
2019-03-31NZ$0.81 B-24.75%
2018-03-31NZ$1.07 B-0.44%
2017-03-31NZ$1.08 B47.93%
2016-03-31NZ$0.73 B-21.37%
2015-03-31NZ$0.92 B8.15%
2014-03-31NZ$0.85 B6.31%
2013-03-31NZ$0.80 B4.77%
2012-03-31NZ$0.77 B10.7%
2011-03-31NZ$0.69 B49.26%
2010-03-31NZ$0.46 B-32.06%
2009-03-31NZ$0.68 B14.45%
2008-03-31NZ$0.60 B-25.22%
2007-03-31NZ$0.80 B-29.87%
2006-03-31NZ$1.14 B1153.14%
2005-03-31NZ$91.38 M423.5%
2004-03-31NZ$17.45 M39.26%
2003-03-31NZ$12.53 M76.7%
2002-03-31NZ$7.09 M-96.66%
2001-03-31NZ$0.21 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
NZ$105.22 B 9,134.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.52 B 2,491.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$41.26 B 3,521.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$55.37 B 4,759.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$44.15 B 3,774.71%๐Ÿ‡ซ๐Ÿ‡ท France